Regulation of p53 expression by the RAS-MAP kinase pathway

被引:42
作者
Agarwal, ML [1 ]
Ramana, CV [1 ]
Hamilton, M [1 ]
Taylor, WR [1 ]
DePrimo, SE [1 ]
Bean, LJH [1 ]
Agarwal, A [1 ]
Agarwal, MK [1 ]
Wolfman, A [1 ]
Stark, GR [1 ]
机构
[1] Cleveland Clin Fdn, Lerner Res Inst, Cleveland, OH 44195 USA
关键词
mutant cells; p53; mRNA levels; p21; expression;
D O I
10.1038/sj.onc.1204353
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Activation of MAP kinase leads to the activation of p53-dependent pathways, and vice-versa. Although the amount of p53 protein increases in response to MAP kinase-dependent signaling, the basis of this increase is not yet fully understood. We have isolated the mutant cell line AP14, defective in p53 expression, from human HT1080 fibrosarcoma cells, which have an activated ras allele, The expression of p53 mRNA and protein is similar to 10-fold lower in AP14 cells than in the parental cells. The high constitutive phosphorylation and activities of the MAP kinases ERK1 and ERK2 in HT1080 cells are greatly reduced in AP14 cells, although the levels of these proteins are unchanged, suggesting that the defect in the mutant cells affects the steady-state phosphorylation of ERK1 and ERK2, Overexpression of ERK2 in AP14 cells restored both MAP kinase activity and p53 expression, and incubation of the mutant cells with the phosphatase inhibitor orthovanadate resulted in strong coordinate elevation of MAP kinase activity and p53 expression. The levels of expression of the p53-regulated gene p21 parallel those of p53 throughout, showing that basal p21 expression depends on p53, The levels of p53 mRNA increased by 5-8-fold when activated ras was introduced into wild-type cells, and the levels of the p53 and p21 proteins decreased substantially in wild-type cells treated with the MEK inhibitor U0216, We conclude that MAP kinase-dependent pathways help to regulate p53 levels by regulating the expression of p53 mRNA.
引用
收藏
页码:2527 / 2536
页数:10
相关论文
共 42 条
  • [1] The p53 network
    Agarwal, ML
    Taylor, WR
    Chernov, MV
    Chernova, OB
    Stark, GR
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (01) : 1 - 4
  • [2] EVIDENCE THAT WILD-TYPE TP53, AND NOT GENES ON EITHER CHROMOSOME-I OR CHROMOSOME-II, CONTROLS THE TUMORIGENIC PHENOTYPE OF THE HUMAN FIBROSARCOMA HT1080
    ANDERSON, MJ
    CASEY, G
    FASCHING, CL
    STANBRIDGE, EJ
    [J]. GENES CHROMOSOMES & CANCER, 1994, 9 (04) : 266 - 281
  • [3] [Anonymous], MOL CLONING
  • [4] [Anonymous], 1988, Antibodies: A Laboratory Manual
  • [5] P53 MUTATIONS ARE COMMON IN PANCREATIC-CANCER AND ARE ABSENT IN CHRONIC-PANCREATITIS
    CASEY, G
    YAMANAKA, Y
    FRIESS, H
    KOBRIN, MS
    LOPEZ, ME
    BUCHLER, M
    BEGER, HG
    KORC, M
    [J]. CANCER LETTERS, 1993, 69 (03) : 151 - 160
  • [6] HIGH-EFFICIENCY TRANSFORMATION OF MAMMALIAN-CELLS BY PLASMID DNA
    CHEN, C
    OKAYAMA, H
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1987, 7 (08) : 2745 - 2752
  • [7] The mitogen-activated protein kinase phosphatases PAC1, MKP-1, and MKP-2 have unique substrate specificities and reduced activity in vivo toward the ERK2 sevenmaker mutation
    Chu, YF
    Solski, PA
    KhosraviFar, R
    Der, CJ
    Kelly, K
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (11) : 6497 - 6501
  • [8] THE TUMOR-SUPPRESSOR P53 REGULATES ITS OWN TRANSCRIPTION
    DEFFIE, A
    WU, HY
    REINKE, V
    LOZANO, G
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (06) : 3415 - 3423
  • [9] Identification of a novel inhibitor of mitogen-activated protein kinase kinase
    Favata, MF
    Horiuchi, KY
    Manos, EJ
    Daulerio, AJ
    Stradley, DA
    Feeser, WS
    Van Dyk, DE
    Pitts, WJ
    Earl, RA
    Hobbs, F
    Copeland, RA
    Magolda, RL
    Scherle, PA
    Trzaskos, JM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (29) : 18623 - 18632
  • [10] INVITRO ESTABLISHMENT IS NOT A SUFFICIENT PREREQUISITE FOR TRANSFORMATION BY ACTIVATED RAS ONCOGENES
    FRANZA, BR
    MARUYAMA, K
    GARRELS, JI
    RULEY, HE
    [J]. CELL, 1986, 44 (03) : 409 - 418